evolcSign inStart free
Menu

StemSight

Develops stem-cell therapies for corneal blindness for patients with unmet medical needs

Tampere, FinlandFounded 2021stemsight.fiWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-03

About StemSight

StemSight develops off-the-shelf cell therapies for corneal blindness, combining induced pluripotent stem cell-derived cells with functional biomaterials to support tissue regeneration and cell delivery.

The company was founded in 2021 by scientists from the Skottman Lab. Its team includes specialists in research and development, clinical development, regulatory affairs, and commercial partnerships.

Product: Off-the-shelf regenerative cell therapies for corneal blindness using stem-cell-derived cells and functional biomaterials.

Jobs at StemSight

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Suomen Lääkekehityskeskus

    State-owned Finnish company that helps university researchers take drug compounds from early discovery to clinical studies
    Turku, FinlandBiotech & pharmaFounded 2022
    Young companyNew on Evolc

  • SwitchPoint Bio

    Epigenomics and AI platform for biopharma and clinical research teams developing biomarkers and stratifying patients
    Helsinki, FinlandBiotech & pharmaFounded 2025
    Young companyNew on Evolc

  • Symeres Finland

    Preclinical ADME-Tox research services for pharmaceutical and biotechnology companies
    Oulu, FinlandBiotech & pharmaFounded 20111 open job
    New on Evolc

  • Synbio Powerlabs

    Bioprocess research and pilot-scale fermentation services for biotechnology companies
    Lappeenranta, FinlandBiotech & pharmaFounded 2022
    Young companyNew on Evolc

  • SYRINX Bioanalytics

    Biomarker and bioanalytical lab services for pharma and biotech clinical trials, from labs in Turku, Manchester and Cape Town
    Turku, FinlandBiotech & pharmaFounded 2007
    New on Evolc

  • Tenboron

    Develops boron carriers for neutron capture cancer radiotherapy, with lead candidate TB0010 for head and neck cancer
    Helsinki, FinlandBiotech & pharmaFounded 2010
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Content delivery

Content management

  • HubSpot CMSMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

CRM & customer data

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.